Imidazoline derivatives having CB1-antagonistic activity

Details for Australian Patent Application No. 2005214084 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Van Stuivenberg, Herman H.; Kruse, Cornelis G.; Lange, Josephus H. M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005214084

PCT Pub. Number WO2005/080345

Priority 04100656.0 19.02.04 EP; 60/545,484 19.02.04 US

Filing date 16 February 2005

Wipo publication date 1 September 2005

Acceptance publication date 3 June 2010

International Classifications

C07D 233/28 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/080345 Priority application(s): WO2005/080345

3 June 2010 Application Accepted

  Published as AU-B-2005214084

30 September 2010 Standard Patent Sealed

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005214088-Alkyl carbamate-substituted butyrolactones, process for their preparation, and pharmaceutical compositions containing them

2005214077-Methods and compositions for inferring eye color and hair color